TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T92521	Cytochrome P450 1B1	D06XMU	Testosterone	Approved	6013	C19H28O2	288.4	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C	Ki = 411800 nM	Non binder
T92521	Cytochrome P450 1B1	D0F7XT	Fluoxetine	Phase 3	3386	C17H18F3NO	309.33	CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F	IC50 = 475000 nM	Non binder
T92521	Cytochrome P450 1B1	B8V4JA	Furafylline	Investigative	3433	C12H12N4O3	260.25	CC1=NC2=C(N1)C(=O)N(C(=O)N2CC3=CC=CO3)C	Ki > 200000 nM	Non binder
T92521	Cytochrome P450 1B1	BFV98Z	4-[(E)-Morpholin-4-yldiazenyl]benzoic acid	Investigative	799928	C11H13N3O3	235.24	C1COCCN1N=NC2=CC=C(C=C2)C(=O)O	IC50 = 400000 nM	Non binder
T92521	Cytochrome P450 1B1	BIC3P0	Bergamottin	Investigative	5471349	C21H22O4	338.4	CC(=CCC/C(=C/COC1=C2C=CC(=O)OC2=CC3=C1C=CO3)/C)C	Ki = 587000 nM	Non binder